what is gip/glp-1 GLP-1 & GIP Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) GLP-1 & GIP Agonists |

With Semaglutide patents expiring in 2026, Indian pharma has a chance to lead the GLP-1 drug market.

'(Semaglutide)'

The medication's success underscores the value of targeting incretin pathways in treating metabolic disorders and highlights the chronic nature of conditions like obesity that benefit from ongoing management rather than short-term interventions

I take this drug myself, so I've been sitting with this question from the other side of the counter

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in people with diabetes.

We subsequently developed an in vivo technique to assess gut hormone release into the portal vein following colonic infusion of propionate